MPWT
ESPR

MassMutual Private Wealth & Trust’s Esperion Therapeutics ESPR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48K Sell
2,050
-450
-18% -$1.26K ﹤0.01% 1587
2026
Q1 		$6.85K Buy
2,500
+1,268
+103% +$4.01K ﹤0.01% 1533
2025
Q4 		$4.56K Buy
1,232
+492
+66% +$1.59K ﹤0.01% 1716
2025
Q3 		$1.96K Buy
+740
New +$1.43K ﹤0.01% 1992
2025
Q2 		– Sell
-1,394
Closed -$2.01K – 2397
2025
Q1 		$2.01K Buy
+1,394
New +$2.57K ﹤0.01% 1914
2022
Q4 		– Sell
-40
Closed – – 1702
2022
Q3 		$0 Buy
+40
New +$275 ﹤0.01% 1670

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
FIA
FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
ACA
Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return
CSB
City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return